BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 7165161)

  • 1. Elimination of naturally acquired chronic Anaplasma marginale infections with a long-acting oxytetracycline injectable.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1982 Dec; 43(12):2170-2. PubMed ID: 7165161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of cattle upon reexposure to Anaplasma marginale after elimination of chronic carrier infections.
    Magonigle RA; Newby TJ
    Am J Vet Res; 1984 Apr; 45(4):695-7. PubMed ID: 6731981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bovine anaplasmosis: elimination of the carrier state with injectable long-acting oxytetracycline.
    Swift BL; Thomas GM
    J Am Vet Med Assoc; 1983 Jul; 183(1):63-5. PubMed ID: 6874524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of five daily intravenous treatments with oxytetracycline hydrochloride on the carrier status of bovine anaplasmosis.
    Magonigle RA; Renshaw HW; Vaughn HW; Stauber EH; Frank FW
    J Am Vet Med Assoc; 1975 Dec; 167(12):1080-3. PubMed ID: 1194114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaplasma marginale infections in American bison: experimental infection and serologic study.
    Zaugg JL; Kuttler KL
    Am J Vet Res; 1985 Feb; 46(2):438-41. PubMed ID: 3994109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of the carrier state of bovine anaplasmosis with a long-acting oxytetracycline.
    Roby TO; Simpson JE; Amerault TE
    Am J Vet Res; 1978 Jul; 39(7):1115-6. PubMed ID: 677530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine anaplasmosis: clinical, hematologic, and serologic manifestations in cows given a long-acting oxytetracycline formulation in the prepatent period.
    Lincoln SD; Eckblad WP; Magonigle RA
    Am J Vet Res; 1982 Aug; 43(8):1360-2. PubMed ID: 7103219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serologic and clinical responses of premunized, vaccinated, and previously infected cattle to challenge exposure by two different Anaplasma marginale isolates.
    Kuttler KL; Zaugg JL; Johnson LW
    Am J Vet Res; 1984 Nov; 45(11):2223-6. PubMed ID: 6084430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine anaplasmosis: susceptibility of seronegative cows from an infected herd to experimental infection with Anaplasma marginale.
    Lincoln SD; Zaugg JL; Maas J
    J Am Vet Med Assoc; 1987 Jan; 190(2):171-3. PubMed ID: 3818429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative titration of Anaplasma marginale antibodies by card agglutination and complement-fixation tests.
    Amerault TE; Rose JE; Kuttler KL
    Am J Vet Res; 1981 Jun; 42(6):1055-6. PubMed ID: 7283236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of a second Anaplasma exposure on the success of treatment to eliminate Anaplasma carrier infections in cattle.
    Kuttler KL
    Am J Vet Res; 1983 May; 44(5):882-3. PubMed ID: 6869997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy of enrofloxacin, imidocarb, and oxytetracycline for clearance of persistent Anaplasma marginale infections in cattle.
    Coetzee JF; Apley MD; Kocan KM
    Vet Ther; 2006; 7(4):347-60. PubMed ID: 17216590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of a short and a long acting oxytetracycline for the treatment of Anaplasma marginale in splenectomized calves.
    Stewart CG; Immelman A; Grimbeek P; Grib D
    J S Afr Vet Assoc; 1979 Jun; 50(2):83-5. PubMed ID: 551196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment with a dithiosemicarbazone and oxytetracycline to eliminate Anaplasma marginale infections in splenectomized calves.
    Kuttler KL
    Res Vet Sci; 1972 Nov; 13(6):536-9. PubMed ID: 4648995
    [No Abstract]   [Full Text] [Related]  

  • 15. Anaplasma ovis in Idaho sheep.
    Magonigle RA; Eckblad WP; Lincoln SD; Frank FW
    Am J Vet Res; 1981 Feb; 42(2):199-201. PubMed ID: 7258767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative persistence of capillary tube-agglutination and complement-fixation test reactions in cattle treated to destroy the carrier state of anaplasmosis.
    Jatkar PR; Kreier JR; Akin EL; Tharp V
    Am J Vet Res; 1966 Jan; 27(116):372-4. PubMed ID: 5950165
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of a new long-acting oxytetracycline formulation against anaplasmosis in colombian cattle.
    Todorovic RA; Gonzalez EF; Garcia O
    Tropenmed Parasitol; 1979 Jun; 30(2):236-8. PubMed ID: 483386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serologic and hematologic response of rabbits to Anaplasma marginale-infected bovine erythrocytes.
    Amerault TE; Mazzola V; Roby TO; Ilemobade AA
    Am J Vet Res; 1978 Apr; 39(4):675-7. PubMed ID: 646203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low levels of chlortetracycline for anaplasmosis.
    Richey EJ; Brock WE; Kliewer IO; Jones EW
    Am J Vet Res; 1977 Feb; 38(2):171-2. PubMed ID: 557303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an indirect fluorescent antibody test, using microfluorometry as a diagnostic test for bovine anaplasmosis.
    Goff WL; Johnson WC; Kuttler KL
    Am J Vet Res; 1985 May; 46(5):1080-4. PubMed ID: 3890629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.